110
edits
m (note about MALT lymphoma) |
(hive off hairy cell leukemia to its own page) |
||
(74 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
''' | The '''small cell lymphomas''' are a collection of commonly seen [[lymphoma]]s that have a near-identical histomorphologic appearance. | ||
The group includes: | The group includes: | ||
#Small lymphocytic lymphoma/chronic lymphocytic leukemia. | #Small lymphocytic lymphoma/[[chronic lymphocytic leukemia]]. | ||
#Follicular lymphoma. | #[[Follicular lymphoma]]. | ||
#Mantle cell lymphoma. | #[[Mantle cell lymphoma]]. | ||
#Marginal zone lymphoma (includes ''MALT lymphoma''). | #[[Marginal zone lymphoma]] (includes ''[[MALT lymphoma]]''). | ||
#Hairy cell leukemia. | #[[Hairy cell leukemia]]. | ||
#Immunoproliferative small intestinal disease (IPSID).<ref name=pmid15542584>{{cite journal |author=Al-Saleem T, Al-Mondhiry H |title=Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms |journal=Blood |volume=105 |issue=6 |pages=2274–80 |year=2005 |month=March |pmid=15542584 |doi=10.1182/blood-2004-07-2755 |url=http://bloodjournal.hematologylibrary.org/cgi/content/long/105/6/2274}}></ref> | #Immunoproliferative small intestinal disease (IPSID).<ref name=pmid15542584>{{cite journal |author=Al-Saleem T, Al-Mondhiry H |title=Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms |journal=Blood |volume=105 |issue=6 |pages=2274–80 |year=2005 |month=March |pmid=15542584 |doi=10.1182/blood-2004-07-2755 |url=http://bloodjournal.hematologylibrary.org/cgi/content/long/105/6/2274}}></ref> | ||
Line 20: | Line 20: | ||
! Other | ! Other | ||
|- | |- | ||
| Follicular lymphoma | | [[Follicular lymphoma]] | ||
| Follicle | | Follicle | ||
| Small, centrocytes, centroblasts | | Small, centrocytes, centroblasts | ||
| CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| t(14 | | t(14;18)(q32;q21) IGH/BCL2<ref name=pmid21192062>{{Cite journal | last1 = Yanai | first1 = S. | last2 = Nakamura | first2 = S. | last3 = Takeshita | first3 = M. | last4 = Fujita | first4 = K. | last5 = Hirahashi | first5 = M. | last6 = Kawasaki | first6 = K. | last7 = Kurahara | first7 = K. | last8 = Sakai | first8 = Y. | last9 = Matsumoto | first9 = T. | title = Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients. | journal = Cancer | volume = | issue = | pages = | month = Dec | year = 2010 | doi = 10.1002/cncr.25811 | PMID = 21192062 }}</ref> | ||
| | | may transform into DLBCL | ||
| | | very common | ||
|- | |- | ||
| Mantle cell lymphoma | | Mantle cell lymphoma | ||
| | | mantle zone | ||
| | | small | ||
| CD5+, CD23-, CD43+, cyclin D1+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD5+, [[CD23]]-, CD43+, cyclin D1+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| t(11;14)(q13;q32)<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref> | | t(11;14)(q13;q32) BCL1/IGH<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref> (also IGH/BCL1<ref>URL: [http://www.wipo.int/patentscope/search/en/WO2010059499 http://www.wipo.int/patentscope/search/en/WO2010059499]. Accessed on: 26 May 2011.</ref>) | ||
| | | aggressive, poor prognosis<ref name=pmid10583923>{{Cite journal | last1 = Hankin | first1 = RC. | last2 = Hunter | first2 = SV. | title = Mantle cell lymphoma. | journal = Arch Pathol Lab Med | volume = 123 | issue = 12 | pages = 1182-8 | month = Dec | year = 1999 | doi = 10.1043/0003-9985(1999)1231182:MCL2.0.CO;2 | PMID = 10583923 }}</ref> | ||
| | | DDx: [[Castleman disease]] | ||
|- | |- | ||
| Marginal zone lymphoma (MALT) | | Marginal zone lymphoma (includes MALT) | ||
| | | [[lymph node|marginal zone]], [[spleen]], GI tract | ||
| | | small | ||
| CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| | | t(11;18)(q21;q21) / API2‐MALT1, t(14;18)(q32;q21) / IGH‐MALT1, t(1;14)(p22;q32) / IGH‐BCL10<ref name=pmid16950858>{{cite journal |author=Bacon CM, Du MQ, Dogan A |title=Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists |journal=J. Clin. Pathol. |volume=60 |issue=4 |pages=361–72 |year=2007 |month=April |pmid=16950858 |pmc=2001121 |doi=10.1136/jcp.2005.031146 |url=}}</ref> | ||
| | |||
| | | classical GI lymphoma | ||
| subtypes: extranodal marginal zone lymphoma ([[AKA]] MALT lymphoma), SMZL, nodal marginal zone lymphoma | |||
|- | |- | ||
| Precursor B cell lymphoblastic lymphoma/leukemia | | Precursor B cell lymphoblastic lymphoma/leukemia | ||
| | | location ? | ||
| | | small | ||
| CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| | | t(9;22), others | ||
| | | good prognosis (?) | ||
| | | other ? | ||
|- | |- | ||
| B cell small lymphocytic lymphoma /<br>chronic lymphocytic leukemia | | B cell small lymphocytic lymphoma /<br>chronic lymphocytic leukemia | ||
| | | location ? | ||
| | | small | ||
| CD5+, CD23+, CD43+, cyclin D1- | | CD5+, [[CD23]]+, CD43+, cyclin D1- | ||
| | | trisomy 12; deletions of 11q, 13q, 17p<ref>{{Ref PCPBoD8|318}}</ref> | ||
| | | good prognosis / indolent course | ||
| | | other ? | ||
|- <!-- | |- <!-- | ||
| Name/entity ? | | Name/entity ? | ||
| | | location ? | ||
| | | size of cells ? | ||
| IHC ? | | IHC ? | ||
| | | translocations ? | ||
| | | clinical ? | ||
| | | other ? --> | ||
|} | |} | ||
Common medium and large cell lymphomas: | |||
{| class="wikitable" | {| class="wikitable" | ||
! Name | ! Name | ||
Line 76: | Line 77: | ||
! IHC | ! IHC | ||
! Translocations | ! Translocations | ||
! Clinical | ! Clinical | ||
! Other | ! Other | ||
|- | |- | ||
| Burkitt's lymphoma | | [[Burkitt's lymphoma]] | ||
| | | follicle | ||
| | | large cells | ||
| CD10, BCL6 | | CD10, BCL6 | ||
| t(8;14) (q24;q32) | | t(8;14) (q24;q32) | ||
| | | rapid growth | ||
| " | | "starry sky" | ||
|- | |- | ||
| Diffuse large B cell lymphoma | | [[Diffuse large B cell lymphoma]] | ||
| | | follicle (?) | ||
| | | large 4-5X of lymphocyte | ||
| | | MIB1 >40% | ||
| none/like follicular l. | | none/like follicular l. | ||
| | | poor prognosis | ||
| | | common among lymphomas | ||
<!-- | <!-- | ||
|- | |- | ||
Line 106: | Line 107: | ||
==Follicular lymphoma== | ==Follicular lymphoma== | ||
*Abbreviated ''FL''. | |||
{{Main|Follicular lymphoma}} | |||
* | |||
==Mantle cell lymphoma== | ==Mantle cell lymphoma== | ||
*Abbreviated ''MCL''. | |||
* | {{Main|Mantle cell lymphoma}} | ||
==Marginal zone lymphoma== | ==Marginal zone lymphoma== | ||
{{Main|Marginal zone lymphoma}} | |||
Classification: | |||
* | #Extranodal marginal zone lymphoma. | ||
#*If in ''mucosa-associated lymphoid tissue'' known as a ''MALT lymphoma'', [[AKA]] ''MALToma''. | |||
#Splenic marginal zone lymphoma (SMZL). | |||
#Nodal marginal zone lymphoma (NMZL). | |||
==Hairy cell leukemia== | ==Hairy cell leukemia== | ||
See [[Hairy cell leukemia]] | |||
==B cell small lymphocytic lymphoma/chronic lymphocytic leukemia== | ==B cell small lymphocytic lymphoma/chronic lymphocytic leukemia== | ||
{{Main|B cell small lymphocytic lymphoma/chronic lymphocytic leukemia}} | |||
==Precursor B-cell lymphoblastic lymphoma/leukemia == | ==Precursor B-cell lymphoblastic lymphoma/leukemia == | ||
===General=== | ===General=== | ||
* | *Good prognosis. | ||
*Paediatric - usu. <6 years old. | |||
===Microscopic=== | ===Microscopic=== | ||
Line 286: | Line 144: | ||
*CD10 +ve, TdT +ve, CD99 +ve. | *CD10 +ve, TdT +ve, CD99 +ve. | ||
*CD5 -ve. | *CD5 -ve. | ||
===Molecular=== | |||
Subclassification based on molecular abnormalities (translocations, rearrangements):<ref name=pmid15559730>{{cite journal |author=Randolph TR |title=Advances in acute lymphoblastic leukemia |journal=Clin Lab Sci |volume=17 |issue=4 |pages=235–45 |year=2004 |pmid=15559730 |url=http://findarticles.com/p/articles/mi_qa3890/is_200410/ai_n9429273/pg_2}}</ref> | |||
* t(9;22) / BCR-ABL. | |||
* t(1;19) / E2A-PBX1. | |||
* t(12;21) / ETV-CBFalpha. | |||
* MLL rearrangement. | |||
==Precursor T-cell lymphoblastic lymphoma/leukemia == | ==Precursor T-cell lymphoblastic lymphoma/leukemia == | ||
Line 304: | Line 169: | ||
*[[Haematopathology]]. | *[[Haematopathology]]. | ||
*[[Lymph node pathology]]. | *[[Lymph node pathology]]. | ||
*[[Spleen]]. | |||
==References== | ==References== | ||
Line 309: | Line 175: | ||
[[Category:Haematopathology]] | [[Category:Haematopathology]] | ||
[[Category:Small cell lymphomas]] |
edits